CPHR analyses were initially run on the original four PE conditions (NPE, MinPE, MedPE, MaxPE).
Forced-entry CPHR analyses for both the four and five PE condition models were run separately on the overall visual and auditory datasets in order to investigate the main effects and interactions of: pre-exposure condition, Unusual Experiences, task order, gender and IQ, along with simple contrasts between each PE condition.
Separate forced-entry CPHR analyses with planned simple contrasts were then run for both the high and low positive-schizotypy groups, on the visual and auditory data, dichotomized by median split of the Unusual Experiences scale of the O-LIFE: low UnEx = 0 - 10; high UnEx = 11 - 25.
CPHR analysis revealed a significant main effect of pre-exposure condition (Wald = 10.62; df = 3; p = .014), with simple contrasts revealing an LI effect between the NPE and MaxPE conditions (Wald = 7.99; df = 1; p = .005) and the NPE and MedPE conditions (Wald = 5.01; df = 1; p = .025), but not between the NPE and MinPE conditions (Wald = .274; df = 1; p = .601).
The re-run CPHR analysis, with the new fifth pre-exposure condition (MicroPE) entered into the equation, also revealed a significant main effect of pre-exposure condition (Wald = 24.65; df = 4; p = .001), with simple contrasts revealing an LI effect between the NPE and MaxPE conditions (Wald = 7.91; df = 1; p = .005) and the NPE and MedPE conditions (Wald = 5.24; df = 1; p = .022), but not the NPE and MinPE condition (Wald = .306; df = 1; p = .580).
CPHR analysis revealed no significant main effect of numbers of pre-exposure (Wald = 5.32; df = 3; p = .150).
The company had initiated a reverse merger with Golden Dragon Holding Company, when it entered into an agreement and plan of merger, by and among Golden Dragon Holding Company (GDHC), a Delaware corporation, CannaPharmaRx Inc, a Colorado corporation, and CPHR Acquisition Corp, a newly-formed wholly-owned subsidiary of GDHC, domiciled in Colorado.
Following the eventual completion of the merger and the retirement of the shares of Golden Dragon Holding Company and CPHR, the company will now have a total of approximately 18,953,287 shares of common stock issued and outstanding.